Already a DIA Member? Sign in. Not a member? Join.
Sign in
Not a Member?
4th DIA Cell & Gene Therapy Products Symposium in Japan
Published Date: Mar 01, 2020Development and practical use of these novel therapeutics must address local challenges in Japan within global development strategy
Author(s)
Akiko Ikeda
Associate Director, Regulatory Development Dept.
Janssen Pharmaceutical K.K.
Education Background: Graduated Tokyo University of Pharmacy and Life Sciences / Qualification: Licensed Pharmacist / CURRENT POSITION: Senior Manager of Policy Intelligence Department in Janssen Pharma K.K (Japan), A leader of Regulatory Sub Committee in PhRMA Japan, A member of Contents Committee in DIA Japan / SUMMARY OF PROFESSIONAL EXPERIENCE: 5 years of experiences at regulatory policy and intelligence; About 20 years of experiences at regulatory affair area including development for New drugs (NDA/ PMDA consultation); Started the carrier at Sankyo Co. (Currently Daiichi-Sankyo Co.) in 1986.